These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6611123)

  • 1. Prospects for both precision and accuracy in positron emission tomography.
    Hoffman EJ; van der Stee M; Ricci AR; Phelps ME
    Ann Neurol; 1984; 15 Suppl():S25-34. PubMed ID: 6611123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation in positron emission computed tomography: 6. effect of nonuniform resolution.
    Hoffman EJ; Huang SC; Plummer D; Phelps ME
    J Comput Assist Tomogr; 1982 Oct; 6(5):987-99. PubMed ID: 6982909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction and characterization of scattered events in three-dimensional PET using scanners with retractable septa.
    Cherry SR; Meikle SR; Hoffman EJ
    J Nucl Med; 1993 Apr; 34(4):671-8. PubMed ID: 8455087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of accuracy of PET utilizing a 3-D phantom to simulate the activity distribution of [18F]fluorodeoxyglucose uptake in the human brain.
    Hoffman EJ; Cutler PD; Guerrero TM; Digby WM; Mazziotta JC
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A17-25. PubMed ID: 1997482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with the EEC phantom and test procedures in two block detector scanners.
    Spinks TJ
    Med Prog Technol; 1991; 17(3-4):139-48. PubMed ID: 1839842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of varying physical parameters of a PET system on the accuracy of radioactivity quantitation in vivo.
    Herzog H; Rota Kops E; Schmid A; Feinendegen LE
    Med Prog Technol; 1991; 17(3-4):193-8. PubMed ID: 1839849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional imaging characteristics of the HEAD PENN-PET scanner.
    Karp JS; Freifelder R; Geagan MJ; Muehllehner G; Kinahan PE; Lewitt RM; Shao L
    J Nucl Med; 1997 Apr; 38(4):636-43. PubMed ID: 9098216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved positron emission tomography quantification by Fourier-based restoration filtering.
    Links JM; Leal JP; Mueller-Gaertner HW; Wagner HN
    Eur J Nucl Med; 1992; 19(11):925-32. PubMed ID: 1425779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic monitoring of [11C]diprenorphine in rat brain using a prototype positron imaging device.
    Rajeswaran S; Hume SP; Cremer JE; Young J; Bailey DL; Ashburner J; Luthra SK; Jones AK; Jones T
    J Neurosci Methods; 1991 Dec; 40(2-3):223-32. PubMed ID: 1800857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of collimation on PET image noise due to scatter, random counts, and deadtime.
    Thompson CJ
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A31-7. PubMed ID: 1997485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 1991 Feb; 41(2 ( Pt 1)):163-7. PubMed ID: 1992357
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography-guided stereotactic brain biopsy.
    Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
    Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the performance characteristics of the PC 4600 positron emission tomograph.
    Kearfott KJ; Carroll LR
    J Comput Assist Tomogr; 1984 Jun; 8(3):502-13. PubMed ID: 6609941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroimaging in epilepsy: is there a future for positron emission tomography.
    Sadzot B
    Epilepsia; 1996 Jun; 37(6):511-4. PubMed ID: 8641225
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 17. A computer simulation study on the effects of input function measurement noise in tracer kinetic modeling with positron emission tomography (PET).
    Feng D; Wang X
    Comput Biol Med; 1993 Jan; 23(1):57-68. PubMed ID: 8467639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
    Valk PE; Jagust WJ; Derenzo SE; Huesman RH; Geyer AB; Budinger TF
    Radiology; 1990 Sep; 176(3):783-90. PubMed ID: 2389037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
    Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
    Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of NMR and PET for determining tumor metabolism.
    Miraldi F
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1033-9. PubMed ID: 3528086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.